South & Central America Pharmacokinetics Services Market Forecast to 2031

At 7.0% CAGR, South & Central America Pharmacokinetics Services Market is Projected to be Worth US$ 68.81 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the South & Central America pharmacokinetics services market was valued at US$ 40.03 million in 2023 and is expected to reach US$ 68.81 million by 2031, registering a CAGR of 7.0% from 2023 to 2031. Increasing adoption of in-vivo and in-vitro models for understanding variability in pharmacokinetics and outsourcing of pharmacokinetics services to CROs are among the critical factors attributed to drive the South & Central America pharmacokinetics services market growth.

The collection and handling of huge pharmacokinetic data generated during drug manufacturing are expensive, tedious, and time-consuming tasks. The labor- and cost-intensive nature of these tasks highlights the need for models such as pharmacokinetic simulation models and in vitro-in vivo pharmacokinetic correlation models (IVIVC) for the prediction of pharmacokinetic parameters. The pharmacokinetic simulation model is a tool that interprets drug kinetics in the living environment under specific conditions using computational and mathematical models. In addition, the IVIVC model is a fundamental part of the drug discovery process. Analyzing PK/PD predictions at the early stages of drug development is necessary for lead optimization strategies and also to further reduce attrition rates. There have been significant advancements in the development of new in-vitro and in-vivo strategies to improve and characterize pharmacokinetic properties. IVIVC models are being proposed as a cost-effective alternative to assess the biopharmaceutical properties that analyze the bioavailability of drugs and their application. Hence, such in-vivo and in-vitro models are anticipated to provide lucrative opportunities for the pharmacokinetics services market in the near future.

On the contrary, limited reach of pharmacokinetics service providers in emerging countries hamper the growth of South & Central America pharmacokinetics services market.

Based on drug type, the South & Central America pharmacokinetics services market is segmented small molecule, large molecule, and vaccines. The small molecule segment held 50.3% market share in 2023, amassing US$ 20.15 million. It is projected to garner US$ 36.27 million by 2031 to register 7.6% CAGR during 2023-2031.

In terms of service type, the South & Central America pharmacokinetics services market is categorized into pre-clinical ADME and human studies, PK/PD analysis and reporting, dosing simulations, risk analysis, and others. The pre-clinical ADME and human studies segment held 35.6% share of South & Central America pharmacokinetics services market in 2023, amassing US$ 14.27 million. It is anticipated to garner US$ 26.83 million by 2031 to expand at 8.2% CAGR during 2023-2031.

By therapeutic application, the South & Central America pharmacokinetics services market is segmented into oncology, infectious diseases, neurological disorders, autoimmune diseases, gynecological disorders, cardiovascular diseases, respiratory disorders, and others. The oncology segment held 22.5% market share in 2023, amassing US$ 9.02 million. It is projected to garner US$ 17.03 million by 2031 to register 8.3% CAGR during 2023-2031.

By end user, the South & Central America pharmacokinetics services market is segmented into pharmaceutical and biotechnology companies, contract research organization, and others. The contract research organization segment held 43.5% market share in 2023, amassing US$ 17.39 million. It is projected to garner US$ 31.55 million by 2031 to register 7.7% CAGR during 2023-2031.

By country, the South & Central America pharmacokinetics services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 48.5% share of South & Central America pharmacokinetics services market in 2023. It was assessed at US$ 19.40 million in 2023 and is likely to hit US$ 35.95 million by 2031, registering a CAGR of 8.0% during 2023-2031.

Key players operating in the South & Central America pharmacokinetics services market are Charles River Laboratories International Inc; Eurofins Scientific SE; Certara Inc.; Parexel International Corp; Thermo Fisher Scientific Inc.; Allucent; PACIFIC BIOLABS; and SGS SA, among others

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America pharmacokinetics services market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America pharmacokinetics services market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America pharmacokinetics services market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharmacokinetics Services Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Chronic and Infectious Diseases
4.1.2 Expanding Range of Application of Pharmacokinetic Studies
4.1.3 Outsourcing of Pharmacokinetics Services to CROs
4.2 Market Restraints
4.2.1 Limited Reach of Pharmacokinetics Service Providers in Emerging Countries
4.3 Market Opportunities
4.3.1 Increasing Adoption of In-Vivo and In-Vitro Models for Understanding Variability in Pharmacokinetics
4.4 Future Trend
4.4.1 Increasing Adoption of Big Data Analytics in Pharmacokinetics Services
4.5 Impact of Drivers and Restraints:
5. Pharmacokinetics Services Market – South & Central America Analysis
5.1 South & Central America Pharmacokinetics Services Market Overview
5.2 South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
6. South & Central America Pharmacokinetics Services Market Analysis – by Drug Type
6.1 Overview
6.2 Small Molecule
6.2.1 Overview
6.2.2 Small Molecule: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Large Molecule
6.3.1 Overview
6.3.2 Large Molecule: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7. South & Central America Pharmacokinetics Services Market Analysis – by Service Type
7.1 Overview
7.2 Pre-Clinical ADME and Human Studies
7.2.1 Overview
7.2.2 Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 PK/PD Analysis and Reporting
7.3.1 Overview
7.3.2 PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Dosing Simulations
7.4.1 Overview
7.4.2 Dosing Simulations: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Risk Analysis
7.5.1 Overview
7.5.2 Risk Analysis: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8. South & Central America Pharmacokinetics Services Market Analysis – by Therapeutic Application
8.1 Oncology
8.1.1 Overview
8.1.2 Oncology: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Infectious Diseases
8.2.1 Overview
8.2.2 Infectious Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Neurological Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Autoimmune Diseases
8.4.1 Overview
8.4.2 Autoimmune Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Gynecological Disorders
8.5.1 Overview
8.5.2 Gynecological Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Cardiovascular Diseases
8.6.1 Overview
8.6.2 Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Respiratory Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
9. South & Central America Pharmacokinetics Services Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Contract Research Organization
9.2.1 Overview
9.2.2 Contract Research Organization: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10. South & Central America Pharmacokinetics Services Market – Country Analysis
10.1 South & Central America
10.1.1 South & Central America Pharmacokinetics Services Market Breakdown by Countries, 2023 and 2031 (%)
10.1.1.1 Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.1.3 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.1.4 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.1.5 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.1.6 Brazil: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.2 Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.2.3 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.2.4 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.2.5 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.2.6 Argentina: South & Central America Pharmacokinetics Services Market Breakdown, by End User
10.1.1.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
10.1.1.3.3 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Drug Type
10.1.1.3.4 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Service Type
10.1.1.3.5 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by Therapeutic Application
10.1.1.3.6 Rest of South & Central America: South & Central America Pharmacokinetics Services Market Breakdown, by End User
11. Company Profile
11.1 Charles River Laboratories International Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eurofins Scientific SE
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Certara Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Parexel International Corp
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Thermo Fisher Scientific Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Allucent
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PACIFIC BIOLABS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 SGS SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Research Team
12.2 Glossary of Terms for Pharmacokinetic Services Market

LIST OF TABLES

Table 1. South & Central America Pharmacokinetics Services Market Segmentation
Table 2. Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Drug Type
Table 3. Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type
Table 4. Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 5. Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 6. Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Drug Type
Table 7. Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type
Table 8. Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 9. Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Drug Type
Table 11. Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type
Table 12. Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by Therapeutic Application
Table 13. Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Pharmacokinetics Services Market Segmentation, by Country
Figure 2. South & Central America Pharmacokinetics Services Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Pharmacokinetics Services Market Revenue (US$ Million), 2021-2031
Figure 5. South & Central America Pharmacokinetics Services Market Share (%) – by Drug Type (2023 and 2031)
Figure 6. Small Molecule: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Large Molecule: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Vaccines: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. South & Central America Pharmacokinetics Services Market Share (%) – by Service Type (2023 and 2031)
Figure 10. Pre-Clinical ADME and Human Studies: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. PK/PD Analysis and Reporting: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Dosing Simulations: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Risk Analysis: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. South & Central America Pharmacokinetics Services Market Share (%) – by Therapeutic Application (2023 and 2031)
Figure 16. Oncology: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Infectious Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Neurological Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Autoimmune Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Gynecological Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Cardiovascular Diseases: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Respiratory Disorders: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. South & Central America Pharmacokinetics Services Market Share (%) – by End User (2023 and 2031)
Figure 25. Pharmaceutical and Biotechnology Companies: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Contract Research Organization: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. South & Central America Pharmacokinetics Services Market by Key Countries – Revenue (2023) (US$ Million)
Figure 29. Brazil: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 30. Argentina: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Pharmacokinetics Services Market – Revenue and Forecast to 2031 (US$ Million)